Catherine Schulte
Stock Analyst at Baird
(4.02)
# 578
Out of 4,944 analysts
138
Total ratings
56.03%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,312.67 | -6.30% | 10 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $15 | $12.91 | +16.19% | 13 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $481.63 | +17.73% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $208.47 | +9.85% | 11 | Jul 23, 2025 | |
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $118.46 | +18.18% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.58 | -22.48% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $44.12 | +63.19% | 14 | May 2, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $48.88 | -12.03% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $53.48 | +27.15% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $19.45 | +95.37% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $28.79 | +14.62% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $99.70 | +181.85% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $292.45 | -25.80% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $156.79 | -87.24% | 1 | Jun 28, 2018 |
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,312.67
Upside: -6.30%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $15
Current: $12.91
Upside: +16.19%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $481.63
Upside: +17.73%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $208.47
Upside: +9.85%
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $118.46
Upside: +18.18%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.58
Upside: -22.48%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $44.12
Upside: +63.19%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $48.88
Upside: -12.03%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $53.48
Upside: +27.15%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $19.45
Upside: +95.37%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $28.79
Upside: +14.62%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $99.70
Upside: +181.85%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $292.45
Upside: -25.80%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $156.79
Upside: -87.24%